On the public citation graph

Monoamine oxidase: isoforms and inhibitors in Parkinson's disease and depressive illness

https://doi.org/10.1038/sj.bjp.0706464
0 signed · 654 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/9780470720325.ch10openalex-snapshot
Biogenic Monoamine Metabolism and Functional Activity in Iron‐Deficient Rats: Behavioural Correlates
inferredcites →https://doi.org/10.1007/978-1-349-01085-1_2openalex-snapshot
Monoamine Oxidases and Their Inhibitors
inferredcites →https://doi.org/10.1007/978-3-7091-6499-0_28openalex-snapshot
Increased striatal dopamine production from L-DOPA following selective inhibition of monoamine oxidase B by R(+)-N-propargyl-1-aminoindan (rasagiline) in the monkey
inferredcites →https://doi.org/10.1007/bf01245973openalex-snapshot
Increased life expectancy resulting from addition of l-deprenyl to Madopar� treatment in Parkinson's disease: A longterm study
inferredcites →https://doi.org/10.1007/bf01253131openalex-snapshot
The potentiation of the anti akinetic effect after L-Dopa treatment by an inhibitor of Mao-B, deprenil
inferredcites →https://doi.org/10.1007/bf02246225openalex-snapshot
Biochemistry and pharmacology of moclobemide, a prototype RIMA
inferredcites →https://doi.org/10.1007/pl00022917openalex-snapshot
Depression in Parkinson's disease: its prevalence, diagnosis, and neurochemical background
inferredcites →https://doi.org/10.1007/s00702-004-0212-1openalex-snapshot
Gene expression profiling of parkinsonian substantia nigra pars compacta; alterations in ubiquitin-proteasome, heat shock protein, iron and oxidative stress regulated proteins, cell adhesion/cellular matrix and vesicle trafficking genes
inferredcites →https://doi.org/10.1016/0006-2952(68)90066-xopenalex-snapshot
Some observations upon a new inhibitor of monoamine oxidase in brain tissue
inferredcites →https://doi.org/10.1016/0006-2952(74)90626-1openalex-snapshot
Monoamine oxidase—I
inferredcites →https://doi.org/10.1016/j.brainresrev.2004.12.027openalex-snapshot
Mechanism of neuroprotective action of the anti-Parkinson drug rasagiline and its derivatives
inferredcites →https://doi.org/10.1016/j.tips.2004.11.007openalex-snapshot
Multi-functional drugs for various CNS targets in the treatment of neurodegenerative disorders
inferredcites →https://doi.org/10.1016/s0022-3565(25)38112-7openalex-snapshot
Monoamine oxidase-A inhibitors and dopamine metabolism in rat caudatus: evidence that an increased cytosolic level of dopamine displaces reversible monoamine oxidase-A inhibitors in vivo.
inferredcites →https://doi.org/10.1016/s0161-813x(03)00103-7openalex-snapshot
Therapeutic Applications of Selective and Non-Selective Inhibitors of Monoamine Oxidase A and B that do not Cause Significant Tyramine Potentiation
inferredcites →https://doi.org/10.1034/j.1600-0447.108.s417.7.xopenalex-snapshot
Pharmacotherapy of social phobia
inferredcites →https://doi.org/10.1038/223626a0openalex-snapshot
Multiple Forms of Rat Brain Monoamine Oxidase
inferredcites →https://doi.org/10.1038/225817a0openalex-snapshot
Multiple Forms of Human Brain Mitochondrial Monoamine Oxidase
inferredcites →https://doi.org/10.1038/236225b0openalex-snapshot
Biological Sciences: Human Brain Monoamine Oxidase: Multiple Forms and Selective Inhibitors
inferredcites →https://doi.org/10.1038/311467a0openalex-snapshot
Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors
inferredcites →https://doi.org/10.1038/nrn1537openalex-snapshot
Iron, brain ageing and neurodegenerative disorders
inferredcites →https://doi.org/10.1038/nrn1883openalex-snapshot
The therapeutic potential of monoamine oxidase inhibitors
inferredcites →https://doi.org/10.1038/sj.bjp.0703826openalex-snapshot
Rasagiline [N‐propargyl‐1R(+)‐aminoindan], a selective and potent inhibitor of mitochondrial monoamine oxidase B
inferredcites →https://doi.org/10.1038/sj.bjp.0706355openalex-snapshot
The neurochemical and behavioral effects of the novel cholinesterase–monoamine oxidase inhibitor, ladostigil, in response to L ‐dopa and L ‐tryptophan, in rats
inferredcites →https://doi.org/10.1042/cs0480289openalex-snapshot
Human Platelet Monoamine Oxidase Activity in Iron-Deficiency Anaemia
inferredcites →https://doi.org/10.1056/nejmra041867openalex-snapshot
The Serotonin Syndrome
inferredcites →https://doi.org/10.1074/jbc.m207435200openalex-snapshot
An Iron-responsive Element Type II in the 5′-Untranslated Region of the Alzheimer's Amyloid Precursor Protein Transcript
inferredcites →https://doi.org/10.1093/bja/65.1.79openalex-snapshot
PHARMACOKINETIC AND METABOLIC PROPERTIES OF LUNG
inferredcites →https://doi.org/10.1111/j.1471-4159.1986.tb01747.xopenalex-snapshot
Monoamine Oxidase Activity and Monoamine Metabolism in Brains of Parkinsonian Patients Treated with l‐Deprenyl
inferredcites →https://doi.org/10.1111/j.1471-4159.1989.tb09150.xopenalex-snapshot
Transition Metals, Ferritin, Glutathione, and Ascorbic Acid in Parkinsonian Brains
inferredcites →https://doi.org/10.1111/j.1471-4159.2005.03340.xopenalex-snapshot
Novel multifunctional neuroprotective iron chelator‐monoamine oxidase inhibitor drugs for neurodegenerative diseases: in vitro studies on antioxidant activity, prevention of lipid peroxide formation and monoamine oxidase inhibition
inferredcites →https://doi.org/10.1111/j.1471-4159.2005.03341.xopenalex-snapshot
Novel multifunctional neuroprotective iron chelator‐monoamine oxidase inhibitor drugs for neurodegenerative diseases.In vivoselective brain monoamine oxidase inhibition and prevention of MPTP‐induced striatal dopamine depletion
inferredcites →https://doi.org/10.1111/j.1476-5381.1975.tb06946.xopenalex-snapshot
EFFECTS OF MONOAMINE OXIDASE INHIBITION BY CLORGYLINE, DEPRENIL OR TRANYLCYPROMINE ON 5‐HYDROXYTRYPTAMINE CONCENTRATIONS IN RAT BRAIN AND HYPERACTIVITY FOLLOWING SUBSEQUENT TRYPTOPHAN ADMINISTRATION
inferredcites →https://doi.org/10.1111/j.1476-5381.1977.tb07506.xopenalex-snapshot
EVIDENCE FOR DOPAMINE DEAMINATION BY BOTH TYPE A AND TYPE B MONOAMINE OXIDASE IN RAT BRAIN in vivo AND FOR THE DEGREE OF INHIBITION OF ENZYME NECESSARY FOR INCREASED FUNCTIONAL ACTIVITY OF DOPAMINE AND 5‐HYDROXYTRYPTAMINE
inferredcites →https://doi.org/10.1111/j.1476-5381.1981.tb16772.xopenalex-snapshot
TYRAMINE ANTAGONISTIC PROPERTIES OF AGN 1135, AN IRREVERSIBLE INHIBITOR OF MONOAMINE OXIDASE TYPE B
inferredcites →https://doi.org/10.1111/j.1476-5381.1982.tb09263.xopenalex-snapshot
RELATIONSHIP BETWEEN TYRAMINE POTENTIATION AND SELECTIVE INHIBITION OF MONOAMINE OXIDASE TYPES A AND B IN THE RAT VAS DEFERENS
inferredcites →https://doi.org/10.1111/j.1476-5381.1985.tb08891.xopenalex-snapshot
Modification of blood pressure and nictitating membrane response to sympathetic amines by selective monoamine oxidase inhibitors, types A and B, in the cat
inferredcites →https://doi.org/10.1111/j.1476-5381.1985.tb08927.xopenalex-snapshot
Prevention of dopaminergic toxicity of MPTP in mice by phenylethylamine, a specific substrate of type B monoamine oxidase
inferredcites →https://doi.org/10.1111/j.1527-3458.2003.tb00245.xopenalex-snapshot
Moclobemide: Therapeutic Use and Clinical Studies
inferredcites →https://doi.org/10.1111/j.1527-3458.2005.tb00269.xopenalex-snapshot
Neuroprotection by Rasagiline: A New Therapeutic Approach to Parkinson's Disease?
inferredcites →https://doi.org/10.1124/jpet.102.046953openalex-snapshot
Mapping the Cerebral Monoamine Oxidase Type A: Positron Emission Tomography Characterization of the Reversible Selective Inhibitor [11C]Befloxatone
inferredcites →https://doi.org/10.1139/o69-160openalex-snapshot
Decreased monoamine oxidase activity in liver of iron-deficient rats
inferredcites →https://doi.org/10.1192/bjp.142.5.508openalex-snapshot
L-Deprenil, A Selective Monoamine Oxidase Type B Inhibitor, in the Treatment of Depression: A Double Blind Evaluation
inferredcites →https://doi.org/10.1358/dot.2005.41.6.893613openalex-snapshot
Neuropharmacological, neuroprotective and amyloid precursor processing properties of selective MAO-B inhibitor antiparkinsonian drug, rasagiline
inferredcites →https://doi.org/10.2174/1568007023339003openalex-snapshot
Mutational Analysis of the Serotonergic System: Recent Findings Using Knockout Mice

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.3897/pharmacia.71.e114786zenodo-depositor-declared
Activity of an oleanane-type tritrepenoid saponin from A. glycyphyllos on human recombinant MAO enzymes
inferred← citeshttps://doi.org/10.3897/pharmacia.73.e192975zenodo-depositor-declared
Caffeine-derived compounds as multifunctional neuroprotective agents: antioxidant activity in subcellular models and MAO-A/B inhibition
inferred← citeshttps://doi.org/10.1002/9781118553480.ch14openalex-snapshot
Therapeutic Strategies to Combat the Onset and Progression of Neurological Diseases
inferred← citeshttps://doi.org/10.1002/9781119143802.ch66openalex-snapshot
Neuroprotective Compounds from Marine Microorganisms
inferred← citeshttps://doi.org/10.1002/adma.201801362openalex-snapshot
Overcoming the Blood–Brain Barrier: The Role of Nanomaterials in Treating Neurological Diseases
inferred← citeshttps://doi.org/10.1002/advs.202308677openalex-snapshot
Progress in the Treatment of Central Nervous System Diseases Based on Nanosized Traditional Chinese Medicine
inferred← citeshttps://doi.org/10.1002/ardp.200700159openalex-snapshot
Synthesis and Monoamine Oxidase Inhibitory Activities of 1‐Thiocarbamoyl‐3,5‐diphenyl‐4,5‐dihydro‐1H‐pyrazole Derivatives
inferred← citeshttps://doi.org/10.1002/ardp.201100448openalex-snapshot
Synthesis and Evaluation of Human Monoamine Oxidase Inhibitory Activities of Some 3,5‐Diaryl‐N‐substituted‐4,5‐dihydro‐1H‐pyrazole‐1‐carbothioamide Derivatives
inferred← citeshttps://doi.org/10.1002/ardp.201500317openalex-snapshot
Monoamine Oxidase Inhibitory Activity of Ferulic Acid Amides: Curcumin‐Based Design and Synthesis
inferred← citeshttps://doi.org/10.1002/ardp.201600088openalex-snapshot
Identification of Indole‐Based Chalcones: Discovery of a Potent, Selective, and Reversible Class of MAO‐B Inhibitors
inferred← citeshttps://doi.org/10.1002/ardp.201800309openalex-snapshot
Potent and highly selective dual‐targeting monoamine oxidase‐B inhibitors: Fluorinated chalcones of morpholine versus imidazole
inferred← citeshttps://doi.org/10.1002/ardp.201900177openalex-snapshot
Emerging therapeutic potentials of dual‐acting MAO and AChE inhibitors in Alzheimer's and Parkinson's diseases
inferred← citeshttps://doi.org/10.1002/cbdv.201500367openalex-snapshot
Potent and Selective Monoamine Oxidase‐B Inhibitory Activity: Fluoro‐ vs . Trifluoromethyl‐4‐hydroxylated Chalcone Derivatives
inferred← citeshttps://doi.org/10.1002/cmdc.201402082openalex-snapshot
8‐Benzyltetrahydropyrazino[2,1‐f]purinediones: Water‐Soluble Tricyclic Xanthine Derivatives as Multitarget Drugs for Neurodegenerative Diseases
inferred← citeshttps://doi.org/10.1002/cmdc.201500059openalex-snapshot
Indanones As High‐Potency Reversible Inhibitors of Monoamine Oxidase
inferred← citeshttps://doi.org/10.1002/cmdc.201600122openalex-snapshot
Synthesis, Biochemistry, and Computational Studies of Brominated Thienyl Chalcones: A New Class of Reversible MAO‐B Inhibitors
inferred← citeshttps://doi.org/10.1002/cmdc.201900277openalex-snapshot
Experimental and Computational Evaluation of Piperonylic Acid Derived Hydrazones Bearing Isatin Moieties as Dual Inhibitors of Cholinesterases and Monoamine Oxidases
inferred← citeshttps://doi.org/10.1002/cmdc.201900717openalex-snapshot
Novel, Dual Target‐Directed Annelated Xanthine Derivatives Acting on Adenosine Receptors and Monoamine Oxidase B
inferred← citeshttps://doi.org/10.1002/cmdc.202000305openalex-snapshot
A New Potent and Selective Monoamine Oxidase‐B Inhibitor with Extended Conjugation in a Chalcone Framework: 1‐[4‐(Morpholin‐4‐yl)phenyl]‐5‐phenylpenta‐2,4‐dien‐1‐one
inferred← citeshttps://doi.org/10.1002/cmdc.70330openalex-snapshot
Quinoxaline‐Based Monoamine Oxidase Inhibitors: Design Strategies, Synthesis, Structure–Activity Relationships, and Therapeutic Potential in Neurological Disorders: A Review From 1996 to 2026
inferred← citeshttps://doi.org/10.1002/ddr.21425openalex-snapshot
An investigation of the monoamine oxidase inhibition properties of pyrrolo[3,4‐f]indole‐5,7‐dione and indole‐5,6‐dicarbonitrile derivatives
inferred← citeshttps://doi.org/10.1002/ddr.21576openalex-snapshot
Optimization of pyrrolo[3,4‐f]indole‐5,7‐dione and indole‐5,6‐dicarbonitrile derivatives as inhibitors of monoamine oxidase
inferred← citeshttps://doi.org/10.1002/jccs.202000170openalex-snapshot
Imino isatin derivatives; synthesis, in silico molecular dynamic study over monoamine oxidase B, ADME prediction, and in vitro cytotoxicity evaluation
inferred← citeshttps://doi.org/10.1002/jnr.24027openalex-snapshot
Monoamine oxidase‐A and B activities in the cerebellum and frontal cortex of children and young adults with autism
inferred← citeshttps://doi.org/10.1002/mdc3.70144openalex-snapshot
Management of Anxiety in Parkinson's Disease
inferred← citeshttps://doi.org/10.1002/mds.22636openalex-snapshot
New developments in depression, anxiety, compulsiveness, and hallucinations in Parkinson's disease
inferred← citeshttps://doi.org/10.1002/mgg3.1040openalex-snapshot
Monoamino oxidase alleles correlate with the presence of essential hypertension among hypogonadic patients
inferred← citeshttps://doi.org/10.1002/rmv.2465openalex-snapshot
Virus infection participates in the occurrence and development of human diseases through monoamine oxidase
inferred← citeshttps://doi.org/10.1002/slct.201701213openalex-snapshot
Refining the Structural Features of Chromones as Selective MAO‐B Inhibitors: Exploration of Combined Pharmacophore‐Based 3D‐QSAR and Quantum Chemical Studies
inferred← citeshttps://doi.org/10.1002/slct.202004188openalex-snapshot
An Update of Synthetic Approaches and Structure‐Activity Relationships of Various Classes of Human MAO‐B Inhibitors
inferred← citeshttps://doi.org/10.1002/syn.20686openalex-snapshot
Computational analysis of determinants of dopamine (DA) dysfunction in DA nerve terminals
inferred← citeshttps://doi.org/10.1007/978-1-0716-3662-6_24openalex-snapshot
Enzyme Inhibition Assays for Monoamine Oxidase
inferred← citeshttps://doi.org/10.1007/978-1-4614-1542-8_7openalex-snapshot
β-Carbolines and Neuroprotection: Inhibition of Monoamine Oxidase
inferred← citeshttps://doi.org/10.1007/978-1-4614-3411-5openalex-snapshot
Systems Biology of Parkinson's Disease
inferred← citeshttps://doi.org/10.1007/978-1-4614-3411-5_8openalex-snapshot
Mathematical Models of Dopamine Metabolism in Parkinson’s Disease
inferred← citeshttps://doi.org/10.1007/978-1-60327-252-0_20openalex-snapshot
Dopamine Replacement Therapy in Parkinson’s Disease: Past, Present and Future
inferred← citeshttps://doi.org/10.1007/978-3-030-57231-0_4openalex-snapshot
Molecular Imaging of Depressive Disorders
inferred← citeshttps://doi.org/10.1007/978-3-030-62226-8_15openalex-snapshot
Preparation and Implementation of a High Throughput Virtual Screening Protocol on a Shared Memory GPU Supercomputer
inferred← citeshttps://doi.org/10.1007/978-3-030-71519-9_211-1openalex-snapshot
Neuroprotection and Neurorestoration of Nigra Striatal Dopamine Neurons by Novel Multitarget Drugs, M30
inferred← citeshttps://doi.org/10.1007/978-3-030-71519-9_221-1openalex-snapshot
Psychiatric Disorders in Animal Models of Depression
inferred← citeshttps://doi.org/10.1007/978-3-031-15080-7_211openalex-snapshot
Neuroprotection and Neurorestoration of Nigra Striatal Dopamine Neurons by Novel Multitarget Drugs, M30
inferred← citeshttps://doi.org/10.1007/978-3-031-15080-7_221openalex-snapshot
Psychiatric Disorders in Animal Models of Depression
inferred← citeshttps://doi.org/10.1007/978-3-211-33328-0openalex-snapshot
Oxidative Stress and Neuroprotection
inferred← citeshttps://doi.org/10.1007/978-3-642-40384-2_5openalex-snapshot
Molecular Imaging of Depressive Disorders
inferred← citeshttps://doi.org/10.1007/978-981-13-8731-9_9openalex-snapshot
Polymeric Nanomedicine
inferred← citeshttps://doi.org/10.1007/978-981-99-2657-2_12openalex-snapshot
Role of Target Fishing in Discovery of Novel Anti-Alzheimer’s Agents: In Silico Applications
inferred← citeshttps://doi.org/10.1007/bf02969302openalex-snapshot
Monoamine oxidase inhibitory coumarins from the aerial parts ofDictamnus albus
inferred← citeshttps://doi.org/10.1007/bf02980210openalex-snapshot
Quinolone alkaloids from evodiae fructus and their inhibitory effects on monoamine oxidase
inferred← citeshttps://doi.org/10.1007/s00044-014-0941-0openalex-snapshot
Molecular modeling study on the structural basis of binding mechanism of C6-substituted phthalides with monoamine oxidases
inferred← citeshttps://doi.org/10.1007/s00044-021-02720-xopenalex-snapshot
Dual monoamine oxidase B and acetylcholine esterase inhibitors for treating movement and cognition deficits in a C. elegans model of Parkinson’s disease
inferred← citeshttps://doi.org/10.1007/s00044-023-03042-wopenalex-snapshot
Investigation of the monoamine oxidase inhibition properties of benzoxathiolone derivatives
inferred← citeshttps://doi.org/10.1007/s00044-023-03176-xopenalex-snapshot
Indazole derivatives as novel inhibitors of monoamine oxidase and D-amino acid oxidase
inferred← citeshttps://doi.org/10.1007/s00044-024-03283-3openalex-snapshot
Synthesis and evaluation of 2-methylbenzothiazole derivatives as monoamine oxidase inhibitors
inferred← citeshttps://doi.org/10.1007/s00044-024-03346-5openalex-snapshot
Monoamine oxidase inhibition by thiazole derivatives substituted with the benzenesulfonamide moiety
inferred← citeshttps://doi.org/10.1007/s00044-025-03422-4openalex-snapshot
The inhibition of monoamine oxidase by 2-methylbenzo[d]oxazole derivatives
inferred← citeshttps://doi.org/10.1007/s00204-022-03304-3openalex-snapshot
Roles of selected non-P450 human oxidoreductase enzymes in protective and toxic effects of chemicals: review and compilation of reactions
inferred← citeshttps://doi.org/10.1007/s00210-010-0517-6openalex-snapshot
Inhibition of monoamine oxidase activity by cannabinoids
inferred← citeshttps://doi.org/10.1007/s00210-020-01923-0openalex-snapshot
Effects of CATECHIN on reserpine-induced vacuous chewing movements: behavioral and biochemical analysis
inferred← citeshttps://doi.org/10.1007/s00213-014-3823-8openalex-snapshot
The separate and combined effects of monoamine oxidase inhibition and nicotine on P50 sensory gating
inferred← citeshttps://doi.org/10.1007/s00259-011-1959-xopenalex-snapshot
Imaging of neuroinflammation
inferred← citeshttps://doi.org/10.1007/s00702-009-0281-2openalex-snapshot
Negative emotionality: monoamine oxidase B gene variants modulate personality traits in healthy humans
inferred← citeshttps://doi.org/10.1007/s00702-011-0617-6openalex-snapshot
A proteomics study reveals a predominant change in MaoB expression in platelets of healthy volunteers after high protein meat diet: relationship to the methylation cycle
inferred← citeshttps://doi.org/10.1007/s00702-012-0899-3openalex-snapshot
Rasagiline and selegiline, inhibitors of type B monoamine oxidase, induce type A monoamine oxidase in human SH-SY5Y cells
inferred← citeshttps://doi.org/10.1007/s00702-013-0981-5openalex-snapshot
Motor and nonmotor complications in Parkinson’s disease: an argument for continuous drug delivery?
inferred← citeshttps://doi.org/10.1007/s00702-013-1016-yopenalex-snapshot
Quantum-chemical approach to determining the high potency of clorgyline as an irreversible acetylenic monoamine oxidase inhibitor
inferred← citeshttps://doi.org/10.1007/s00702-014-1257-4openalex-snapshot
Effects of diphenyl diselenide on behavioral and biochemical changes induced by amphetamine in mice
inferred← citeshttps://doi.org/10.1007/s00702-014-1362-4openalex-snapshot
Modulation of monoamine oxidase (MAO) expression in neuropsychiatric disorders: genetic and environmental factors involved in type A MAO expression
inferred← citeshttps://doi.org/10.1007/s00702-017-1709-8openalex-snapshot
Type A monoamine oxidase and serotonin are coordinately involved in depressive disorders: from neurotransmitter imbalance to impaired neurogenesis
inferred← citeshttps://doi.org/10.1007/s00702-017-1740-9openalex-snapshot
Type B and A monoamine oxidase and their inhibitors regulate the gene expression of Bcl-2 and neurotrophic factors in human glioblastoma U118MG cells: different signal pathways for neuroprotection by selegiline and rasagiline
inferred← citeshttps://doi.org/10.1007/s00702-017-1832-6openalex-snapshot
Type A and B monoamine oxidases distinctly modulate signal transduction pathway and gene expression to regulate brain function and survival of neurons
inferred← citeshttps://doi.org/10.1007/s00702-020-02150-wopenalex-snapshot
Rasagiline and selegiline modulate mitochondrial homeostasis, intervene apoptosis system and mitigate α-synuclein cytotoxicity in disease-modifying therapy for Parkinson’s disease
inferred← citeshttps://doi.org/10.1007/s00702-020-02189-9openalex-snapshot
9-Methyl-β-carboline inhibits monoamine oxidase activity and stimulates the expression of neurotrophic factors by astrocytes
inferred← citeshttps://doi.org/10.1007/s00702-024-02793-zopenalex-snapshot
Effects of association between resveratrol and ketamine on behavioral and biochemical analysis in mice
inferred← citeshttps://doi.org/10.1007/s00702-024-02866-zopenalex-snapshot
Type A monoamine oxidase; its unique role in mood, behavior and neurodegeneration
inferred← citeshttps://doi.org/10.1007/s00894-012-1390-7openalex-snapshot
Targeting imidazoline site on monoamine oxidase B through molecular docking simulations
inferred← citeshttps://doi.org/10.1007/s10571-021-01078-3openalex-snapshot
Overview of the Neuroprotective Effects of the MAO-Inhibiting Antidepressant Phenelzine
inferred← citeshttps://doi.org/10.1007/s10822-026-00764-yopenalex-snapshot
The discovery of monoamine oxidase inhibitors: virtual screening and in vitro inhibition potencies
inferred← citeshttps://doi.org/10.1007/s11010-017-3193-8openalex-snapshot
Repetitive transcranial magnetic stimulation inhibits Sirt1/MAO-A signaling in the prefrontal cortex in a rat model of depression and cortex-derived astrocytes
inferred← citeshttps://doi.org/10.1007/s11011-014-9635-zopenalex-snapshot
Antidepressant-like effects of ferulic acid: involvement of serotonergic and norepinergic systems
inferred← citeshttps://doi.org/10.1007/s11011-017-0081-6openalex-snapshot
Methylene blue and its analogues as antidepressant compounds
inferred← citeshttps://doi.org/10.1007/s11030-019-09917-8openalex-snapshot
Synthesis and evaluation of chromone derivatives as inhibitors of monoamine oxidase
inferred← citeshttps://doi.org/10.1007/s11030-019-09960-5openalex-snapshot
The monoamine oxidase inhibition properties of C6- and N1-substituted 3-methyl-3,4-dihydroquinazolin-2(1H)-one derivatives
inferred← citeshttps://doi.org/10.1007/s11030-020-10143-wopenalex-snapshot
The evaluation of 1-tetralone and 4-chromanone derivatives as inhibitors of monoamine oxidase
inferred← citeshttps://doi.org/10.1007/s11030-023-10628-4openalex-snapshot
Monoamine oxidase inhibition properties of 2,1-benzisoxazole derivatives
inferred← citeshttps://doi.org/10.1007/s11033-007-9131-1openalex-snapshot
Identification, expression and tissue distribution of a renalase homologue from mouse
inferred← citeshttps://doi.org/10.1007/s11033-019-04684-zopenalex-snapshot
Isoflavones prevent oxidative stress and inhibit the activity of the enzyme monoamine oxidase in vitro
inferred← citeshttps://doi.org/10.1007/s11033-023-08409-1openalex-snapshot
Targeting Nrf2 signaling pathway and oxidative stress by resveratrol for Parkinson’s disease: an overview and update on new developments
inferred← citeshttps://doi.org/10.1007/s11064-009-9989-5openalex-snapshot
The Low Affinity Dopamine Binding Site on Tyrosine Hydroxylase: The Role of the N-Terminus and In Situ Regulation of Enzyme Activity
inferred← citeshttps://doi.org/10.1007/s11064-012-0882-2openalex-snapshot
Extracellular Superoxide Dismutase Induced by Dopamine in Cultured Astrocytes
inferred← citeshttps://doi.org/10.1007/s11064-014-1477-xopenalex-snapshot
Protein Phosphatase 2A is Involved in the Tyrosine Hydroxylase Phosphorylation Regulated by α-Synuclein
inferred← citeshttps://doi.org/10.1007/s11064-017-2335-4openalex-snapshot
Resveratrol Protects Against Vacuous Chewing Movements Induced by Chronic Treatment with Fluphenazine
inferred← citeshttps://doi.org/10.1007/s11064-024-04275-wopenalex-snapshot
Effects of Acute Haloperidol Treatment on Dopaminergic Markers, GAD67, and A2A Receptors in Rats with High and Low VCMs
inferred← citeshttps://doi.org/10.1007/s12035-019-01832-1openalex-snapshot
The Role of Xenobiotics and Trace Metals in Parkinson’s Disease
inferred← citeshttps://doi.org/10.1007/s12035-025-05401-7openalex-snapshot
Neuropeptide S Protects Dopaminergic Neurons in a Paraquat-Induced Parkinson’s Model Using SH-SY5Y Cells
inferred← citeshttps://doi.org/10.1007/s12325-020-01500-0openalex-snapshot
Multiple-Dose Pharmacokinetics of Ozanimod and its Major Active Metabolites and the Pharmacodynamic and Pharmacokinetic Interactions with Pseudoephedrine, a Sympathomimetic Agent, in Healthy Subjects
inferred← citeshttps://doi.org/10.1007/s12325-021-01873-wopenalex-snapshot
Effectiveness of Safinamide over Mood in Parkinson’s Disease Patients: Secondary Analysis of the Open-label Study SAFINONMOTOR
inferred← citeshttps://doi.org/10.1007/s12640-009-9128-8openalex-snapshot
Limited Potentiation of Blood Pressure in Response to Oral Tyramine by the Anti-Parkinson Brain Selective Multifunctional Monoamine Oxidase-AB Inhibitor, M30
inferred← citeshttps://doi.org/10.1007/s12640-013-9425-0openalex-snapshot
1-Methyl-1,2,3,4-tetrahydroisoquinoline, an Endogenous Neuroprotectant and MAO Inhibitor with Antidepressant-Like Properties in the Rat
inferred← citeshttps://doi.org/10.1007/s13105-012-0160-4openalex-snapshot
Effect of some pyrimidine compounds on rat brain monoamine oxidase-B in vitro
inferred← citeshttps://doi.org/10.1007/s43188-023-00182-4openalex-snapshot
Two weeks dose range-finding and four weeks repeated dose oral toxicity study of a novel reversible monoamine oxidase B inhibitor KDS2010 in cynomolgus monkeys
inferred← citeshttps://doi.org/10.1007/s44371-026-00634-4openalex-snapshot
Artificial intelligence and machine learning based discovery of bioisosteres (BIOS) of FDA approved MAO-B inhibitors for the management of Alzheimer’s disease
inferred← citeshttps://doi.org/10.1016/b0-08-045044-x/00163-2openalex-snapshot
Affective Disorders: Depression and Bipolar Disorders
inferred← citeshttps://doi.org/10.1016/b978-0-08-101011-2.00005-2openalex-snapshot
Dual-Acting Compounds Acting as Receptor Ligands and Enzyme Inhibitors
inferred← citeshttps://doi.org/10.1016/b978-0-12-386467-3.00005-4openalex-snapshot
Type A monoamine oxidase regulates life and death of neurons in neurodegeneration and neuroprotection
inferred← citeshttps://doi.org/10.1016/b978-0-12-386467-3.00007-8openalex-snapshot
Neuroprotective profile of the multitarget drug rasagiline in Parkinson's disease
inferred← citeshttps://doi.org/10.1016/b978-0-12-803959-5.50005-2openalex-snapshot
Multifunctional Enzyme Inhibition for Neuroprotection - A Focus on MAO, NOS, and AChE Inhibitors
inferred← citeshttps://doi.org/10.1016/b978-0-12-812922-7.00010-xopenalex-snapshot
Other Compounds From Tobacco With Potential Impact on Neurodegenerative Diseases
inferred← citeshttps://doi.org/10.1016/b978-0-12-812922-7.09994-7openalex-snapshot
References
inferred← citeshttps://doi.org/10.1016/b978-0-12-816386-3.00047-8openalex-snapshot
PET Imaging of Neuroinflammation
inferred← citeshttps://doi.org/10.1016/b978-0-12-817933-8.00008-6openalex-snapshot
Comorbidities of depression and Parkinson’s disease
inferred← citeshttps://doi.org/10.1016/b978-0-12-823589-8.00012-1openalex-snapshot
Neurodegenerative diseases
inferred← citeshttps://doi.org/10.1016/b978-0-443-33112-1.00004-5openalex-snapshot
Candidate gene studies of suicidal behavior-1: concerning monoamino oxidases (single-nucleotide) polymorphisms
inferred← citeshttps://doi.org/10.1016/b978-0-443-36295-8.00009-2openalex-snapshot
Therapeutic approaches to age related cognitive decline and neurodegenerative diseases
inferred← citeshttps://doi.org/10.1016/b978-0-443-43812-7.00016-2openalex-snapshot
Chalcone-protein co-crystals in the Protein Data Bank
inferred← citeshttps://doi.org/10.1016/b978-0-444-53086-8.00015-1openalex-snapshot
Synthesis and Biochemical Evaluation of Fluorinated Monoamine Oxidase Inhibitors
inferred← citeshttps://doi.org/10.1016/b978-008045046-9.00139-xopenalex-snapshot
Neurotransmitters and Growth Factors: Overview
inferred← citeshttps://doi.org/10.1016/j.ab.2009.10.029openalex-snapshot
Analysis of activity and inhibition of oxygen-dependent enzymes by optical respirometry on the LightCycler system
inferred← citeshttps://doi.org/10.1016/j.ab.2016.06.020openalex-snapshot
A spectrophotometric assay for monoamine oxidase activity with 2, 4-dinitrophenylhydrazine as a derivatized reagent
inferred← citeshttps://doi.org/10.1016/j.aca.2016.03.021openalex-snapshot
Silica stationary phase-based on-line sample enrichment coupled with LC-MS/MS for the quantification of dopamine, serotonin and their metabolites in rat brain microdialysates
inferred← citeshttps://doi.org/10.1016/j.aninu.2025.09.009openalex-snapshot
Early-stage fasting leads to long-term growth inhibition and body composition changes in turbot (Scophthalmus maximus)
inferred← citeshttps://doi.org/10.1016/j.aquatox.2025.107321openalex-snapshot
Neurotoxicity and aggressive behavior induced by anesthetic etomidate exposure in zebrafish: Insights from multi-omics and machine learning
inferred← citeshttps://doi.org/10.1016/j.arabjc.2012.12.034openalex-snapshot
Nitrogen heterocycles as potential monoamine oxidase inhibitors: Synthetic aspects
inferred← citeshttps://doi.org/10.1016/j.arr.2022.101840openalex-snapshot
Neurobiology of depression in Parkinson’s disease: Insights into epidemiology, molecular mechanisms and treatment strategies
inferred← citeshttps://doi.org/10.1016/j.baga.2012.06.007openalex-snapshot
Effects of monoamine oxidase Type B inhibitors on motor and non-motor symptoms in Parkinson’s disease: A systematic comparison of rasagiline and selegiline
inferred← citeshttps://doi.org/10.1016/j.bbapap.2013.11.003openalex-snapshot
Exploring the structural basis of the selective inhibition of monoamine oxidase A by dicarbonitrile aminoheterocycles: Role of Asn181 and Ile335 validated by spectroscopic and computational studies
inferred← citeshttps://doi.org/10.1016/j.bbi.2017.07.010openalex-snapshot
Central serotonin attenuates LPS-induced systemic inflammation
inferred← citeshttps://doi.org/10.1016/j.bbr.2017.12.039openalex-snapshot
The monoamine-oxidase B inhibitor deprenyl increases selection of high-effort activity in rats tested on a progressive ratio/chow feeding choice procedure: Implications for treating motivational dysfunctions
inferred← citeshttps://doi.org/10.1016/j.bbrc.2011.05.075openalex-snapshot
Evaluation of anti-depressant-like activity of linezolid, an oxazolidinone class derivative – An investigation using behavioral tests battery of depression
inferred← citeshttps://doi.org/10.1016/j.bcp.2018.06.024openalex-snapshot
Interactions of endocannabinoid virodhamine and related analogs with human monoamine oxidase-A and -B
inferred← citeshttps://doi.org/10.1016/j.bioorg.2011.10.003openalex-snapshot
Monoamine oxidase inhibition by C4-substituted phthalonitriles
inferred← citeshttps://doi.org/10.1016/j.bioorg.2012.08.003openalex-snapshot
Selected C7-substituted chromone derivatives as monoamine oxidase inhibitors
inferred← citeshttps://doi.org/10.1016/j.bioorg.2013.06.006openalex-snapshot
The adenosine A2A antagonistic properties of selected C8-substituted xanthines
inferred← citeshttps://doi.org/10.1016/j.bioorg.2015.02.005openalex-snapshot
The adenosine receptor affinities and monoamine oxidase B inhibitory properties of sulfanylphthalimide analogues
inferred← citeshttps://doi.org/10.1016/j.bioorg.2015.07.001openalex-snapshot
Development of fluorinated methoxylated chalcones as selective monoamine oxidase-B inhibitors: Synthesis, biochemistry and molecular docking studies
inferred← citeshttps://doi.org/10.1016/j.bioorg.2016.09.004openalex-snapshot
2-Heteroarylidene-1-indanone derivatives as inhibitors of monoamine oxidase
inferred← citeshttps://doi.org/10.1016/j.bioorg.2018.02.003openalex-snapshot
Asymmetric synthesis, molecular modeling and biological evaluation of 5-methyl-3-aryloxazolidine-2,4-dione enantiomers as monoamine oxidase (MAO) inhibitors
inferred← citeshttps://doi.org/10.1016/j.bioorg.2018.12.030openalex-snapshot
The monoamine oxidase inhibition properties of C6-mono- and N3/C6-disubstituted derivatives of 4(3H)-quinazolinone
inferred← citeshttps://doi.org/10.1016/j.bioorg.2019.103335openalex-snapshot
Design, synthesis and biological evaluation of oxygenated chalcones as potent and selective MAO-B inhibitors
inferred← citeshttps://doi.org/10.1016/j.bioorg.2020.103707openalex-snapshot
Pyridoxine-resveratrol hybrids as novel inhibitors of MAO-B with antioxidant and neuroprotective activities for the treatment of Parkinson’s disease
inferred← citeshttps://doi.org/10.1016/j.bioorg.2020.104563openalex-snapshot
Investigation of pyrazolo[1,5-a]quinoxalin-4-ones as novel monoamine oxidase inhibitors
inferred← citeshttps://doi.org/10.1016/j.bioorg.2021.105130openalex-snapshot
The inhibition of catechol O-methyltransferase and monoamine oxidase by tetralone and indanone derivatives substituted with the nitrocatechol moiety
inferred← citeshttps://doi.org/10.1016/j.bioorg.2021.105203openalex-snapshot
Pyridazinones containing dithiocarbamoyl moieties as a new class of selective MAO-B inhibitors
inferred← citeshttps://doi.org/10.1016/j.bioorg.2021.105352openalex-snapshot
Discovery of 3,4-dichloro-N-(1H-indol-5-yl)benzamide: A highly potent, selective, and competitive hMAO-B inhibitor with high BBB permeability profile and neuroprotective action
inferred← citeshttps://doi.org/10.1016/j.bioorg.2022.105791openalex-snapshot
Coumarin derivatives as inhibitors of d-amino acid oxidase and monoamine oxidase
inferred← citeshttps://doi.org/10.1016/j.biopha.2018.04.189openalex-snapshot
Colistin sulphate induced neurotoxicity: Studies on cholinergic, monoaminergic, purinergic and oxidative stress biomarkers
inferred← citeshttps://doi.org/10.1016/j.biopha.2024.116786openalex-snapshot
Comprehensive safety evaluation of a novel multitargeting compound XYY-CP1106: A candidate for Alzheimer's disease
inferred← citeshttps://doi.org/10.1016/j.bmc.2007.03.046openalex-snapshot
Inhibition of monoamine oxidase B by selected benzimidazole and caffeine analogues
inferred← citeshttps://doi.org/10.1016/j.bmc.2007.11.059openalex-snapshot
Structure–activity relationships in the inhibition of monoamine oxidase B by 1-methyl-3-phenylpyrroles
inferred← citeshttps://doi.org/10.1016/j.bmc.2008.07.088openalex-snapshot
Dual inhibition of monoamine oxidase B and antagonism of the adenosine A2A receptor by (E,E)-8-(4-phenylbutadien-1-yl)caffeine analogues
inferred← citeshttps://doi.org/10.1016/j.bmc.2008.09.072openalex-snapshot
Synthesis, structure–activity relationships and molecular modeling studies of new indole inhibitors of monoamine oxidases A and B
inferred← citeshttps://doi.org/10.1016/j.bmc.2009.12.064openalex-snapshot
Inhibition of monoamine oxidase by 8-benzyloxycaffeine analogues
inferred← citeshttps://doi.org/10.1016/j.bmc.2010.11.028openalex-snapshot
Inhibition of monoamine oxidase by selected C5- and C6-substituted isatin analogues
inferred← citeshttps://doi.org/10.1016/j.bmc.2011.06.070openalex-snapshot
Inhibition of monoamine oxidase by C5-substituted phthalimide analogues
inferred← citeshttps://doi.org/10.1016/j.bmc.2011.10.036openalex-snapshot
Thio- and aminocaffeine analogues as inhibitors of human monoamine oxidase
inferred← citeshttps://doi.org/10.1016/j.bmc.2011.10.049openalex-snapshot
Molecular insights into human monoamine oxidase (MAO) inhibition by 1,4-naphthoquinone: Evidences for menadione (vitamin K3) acting as a competitive and reversible inhibitor of MAO
inferred← citeshttps://doi.org/10.1016/j.bmc.2012.05.048openalex-snapshot
Inhibition of monoamine oxidase by 8-phenoxymethylcaffeine derivatives
inferred← citeshttps://doi.org/10.1016/j.bmc.2012.10.005openalex-snapshot
Inhibition of monoamine oxidase by 8-[(phenylethyl)sulfanyl]caffeine analogues
inferred← citeshttps://doi.org/10.1016/j.bmc.2012.10.050openalex-snapshot
Synthesis and biological evaluation of novel propargyl amines as potential fluorine-18 labeled radioligands for detection of MAO-B activity
inferred← citeshttps://doi.org/10.1016/j.bmc.2013.08.019openalex-snapshot
Development of a novel fluorine-18 labeled deuterated fluororasagiline ([18F]fluororasagiline-D2) radioligand for PET studies of monoamino oxidase B (MAO-B)
inferred← citeshttps://doi.org/10.1016/j.bmc.2015.04.021openalex-snapshot
Synthesis and evaluation of quinazoline amino acid derivatives as mono amine oxidase (MAO) inhibitors
inferred← citeshttps://doi.org/10.1016/j.bmc.2016.09.003openalex-snapshot
8-Substituted 1,3-dimethyltetrahydropyrazino[2,1-f]purinediones: Water-soluble adenosine receptor antagonists and monoamine oxidase B inhibitors
inferred← citeshttps://doi.org/10.1016/j.bmc.2016.09.050openalex-snapshot
Neuroprotective effects of benzyloxy substituted small molecule monoamine oxidase B inhibitors in Parkinson’s disease
inferred← citeshttps://doi.org/10.1016/j.bmc.2018.08.024openalex-snapshot
Design, synthesis and biological evaluation of lazabemide derivatives as inhibitors of monoamine oxidase
inferred← citeshttps://doi.org/10.1016/j.bmc.2018.09.032openalex-snapshot
Synthesis and evaluation of 2-substituted 4(3H)-quinazolinone thioether derivatives as monoamine oxidase inhibitors
inferred← citeshttps://doi.org/10.1016/j.bmc.2021.116558openalex-snapshot
Phenothiazine, anthraquinone and related tricyclic derivatives as inhibitors of monoamine oxidase
inferred← citeshttps://doi.org/10.1016/j.bmc.2022.117030openalex-snapshot
Isatoic anhydrides as novel inhibitors of monoamine oxidase
inferred← citeshttps://doi.org/10.1016/j.bmc.2024.117925openalex-snapshot
A review on synthetic inhibitors of dual-specific tyrosine phosphorylation-regulated kinase 1A (DYRK1A) for the treatment of Alzheimer’s disease (AD)
inferred← citeshttps://doi.org/10.1016/j.bmc.2025.118369openalex-snapshot
Targeting Alzheimer's pathology: Tetralone- and thiochromanone-based benzyl pyridinium derivatives as promising multi-target-directed ligands
inferred← citeshttps://doi.org/10.1016/j.bmcl.2008.03.001openalex-snapshot
Ultrasound promoted synthesis of 2-imidazolines in water: A greener approach toward monoamine oxidase inhibitors
inferred← citeshttps://doi.org/10.1016/j.bmcl.2009.03.030openalex-snapshot
Inhibition of monoamine oxidase by (E)-styrylisatin analogues
inferred← citeshttps://doi.org/10.1016/j.bmcl.2010.08.104openalex-snapshot
‘Click’ assembly of selective inhibitors for MAO-A
inferred← citeshttps://doi.org/10.1016/j.bmcl.2011.06.060openalex-snapshot
Structure–activity relationship and docking studies of thiazolidinedione-type compounds with monoamine oxidase B
inferred← citeshttps://doi.org/10.1016/j.bmcl.2012.06.058openalex-snapshot
Synthesis and evaluation of aplysinopsin analogs as inhibitors of human monoamine oxidase A and B
inferred← citeshttps://doi.org/10.1016/j.bmcl.2012.07.025openalex-snapshot
Selected chromone derivatives as inhibitors of monoamine oxidase
inferred← citeshttps://doi.org/10.1016/j.bmcl.2012.08.113openalex-snapshot
Novel sulfanylphthalimide analogues as highly potent inhibitors of monoamine oxidase B
inferred← citeshttps://doi.org/10.1016/j.bmcl.2012.10.070openalex-snapshot
Sulfanylphthalonitrile analogues as selective and potent inhibitors of monoamine oxidase B
inferred← citeshttps://doi.org/10.1016/j.bmcl.2013.01.003openalex-snapshot
Inhibition of monoamine oxidase by phthalide analogues
inferred← citeshttps://doi.org/10.1016/j.bmcl.2013.08.071openalex-snapshot
Inhibition of monoamine oxidase by 3,4-dihydro-2(1H)-quinolinone derivatives
inferred← citeshttps://doi.org/10.1016/j.bmcl.2014.04.021openalex-snapshot
α-Tetralone derivatives as inhibitors of monoamine oxidase
inferred← citeshttps://doi.org/10.1016/j.bmcl.2014.11.007openalex-snapshot
α-Ketoamino acid ester derivatives as promising MAO inhibitors
inferred← citeshttps://doi.org/10.1016/j.bmcl.2015.01.061openalex-snapshot
Inhibition of monoamine oxidase by indole-5,6-dicarbonitrile derivatives
inferred← citeshttps://doi.org/10.1016/j.bmcl.2015.03.040openalex-snapshot
The synthesis and evaluation of sesamol and benzodioxane derivatives as inhibitors of monoamine oxidase
inferred← citeshttps://doi.org/10.1016/j.bmcl.2015.09.049openalex-snapshot
Monoamine oxidase inhibitory activities of heterocyclic chalcones
inferred← citeshttps://doi.org/10.1016/j.bmcl.2016.01.034openalex-snapshot
Inhibition of monoamine oxidase by benzoxathiolone analogues
inferred← citeshttps://doi.org/10.1016/j.bmcl.2016.03.060openalex-snapshot
An evaluation of synthetic indole derivatives as inhibitors of monoamine oxidase
inferred← citeshttps://doi.org/10.1016/j.bmcl.2016.08.067openalex-snapshot
2-Benzylidene-1-indanone derivatives as inhibitors of monoamine oxidase
inferred← citeshttps://doi.org/10.1016/j.bmcl.2017.01.003openalex-snapshot
Study of antileishmanial activity of 2-aminobenzoyl amino acid hydrazides and their quinazoline derivatives
inferred← citeshttps://doi.org/10.1016/j.bmcl.2019.126677openalex-snapshot
1,3,4-Oxadiazol-2-ylbenzenesulfonamides as privileged structures for the inhibition of monoamine oxidase B
inferred← citeshttps://doi.org/10.1016/j.bmcl.2020.127188openalex-snapshot
Evaluation of nitrocatechol chalcone and pyrazoline derivatives as inhibitors of catechol-O-methyltransferase and monoamine oxidase
inferred← citeshttps://doi.org/10.1016/j.bmcl.2022.128746openalex-snapshot
The evaluation of N-propargylamine-2-aminotetralin as an inhibitor of monoamine oxidase
inferred← citeshttps://doi.org/10.1016/j.bmcl.2022.129038openalex-snapshot
The inhibition of monoamine oxidase by 2H-1,4-benzothiazin-3(4H)-ones
inferred← citeshttps://doi.org/10.1016/j.brainres.2015.08.033openalex-snapshot
Autophagy-related protein expression in the substantia nigra and eldepryl intervention in rat models of Parkinson׳s disease
inferred← citeshttps://doi.org/10.1016/j.brainres.2017.03.032openalex-snapshot
Subchronic glucocorticoids, glutathione depletion and a postpartum model elevate monoamine oxidase a activity in the prefrontal cortex of rats
inferred← citeshttps://doi.org/10.1016/j.brainresbull.2020.12.018openalex-snapshot
Safinamide in neurological disorders and beyond: Evidence from preclinical and clinical studies
inferred← citeshttps://doi.org/10.1016/j.cbi.2007.07.013openalex-snapshot
Differential effects of selegiline on glucose synthesis in rabbit kidney-cortex tubules and hepatocytes
inferred← citeshttps://doi.org/10.1016/j.cbi.2013.11.012openalex-snapshot
Effect of Cd, Zn and Hg complexes of barbituric acid and thiouracil on rat brain monoamine oxidase-B (in vitro)
inferred← citeshttps://doi.org/10.1016/j.cbi.2016.06.005openalex-snapshot
Combining in vitro and in silico approaches to evaluate the multifunctional profile of rosmarinic acid from Blechnum brasiliense on targets related to neurodegeneration
inferred← citeshttps://doi.org/10.1016/j.cbpc.2020.108873openalex-snapshot
Inhibition of monoamine oxidase attenuates social defeat-induced memory impairment in goldfish, (Carassius auratus): A possible involvement of synaptic proteins and BDNF
inferred← citeshttps://doi.org/10.1016/j.ceca.2010.08.008openalex-snapshot
Novel pathway for an old neurotransmitter: Dopamine-induced neuronal calcium signalling via receptor-independent mechanisms
inferred← citeshttps://doi.org/10.1016/j.ceca.2021.102359openalex-snapshot
Dopamine controls neuronal spontaneous calcium oscillations via astrocytic signal
showing the first 200 of 610
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.